Back to top
more

AMN Healthcare Services (AMN)

(Real Time Quote from BATS)

$16.72 USD

16.72
1,014,022

-0.20 (-1.18%)

Updated Aug 8, 2025 01:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (97 out of 244)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top

by Zacks Equity Research

OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.

Zacks Equity Research

Here's Why You Should Hold on to CVS Health (CVS) For Now

by Zacks Equity Research

Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.

Zacks Equity Research

Best Growth Stocks to Buy for May 10th

by Zacks Equity Research

AMN, GEO, and AA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 10, 2022.

Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

Zacks Equity Research

AMN Healthcare (AMN) Q1 Earnings, Revenues Beat Estimates

by Zacks Equity Research

AMN Healthcare's (AMN) robust Q1 results demonstrate its segmental strength.

Zacks Equity Research

AMN Healthcare Services (AMN) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 7.38% and 3.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Zacks Equity Research

Here's Why You Should Hold on to Edwards Lifesciences (EW) Now

by Zacks Equity Research

Investors are optimistic about Edwards Lifesciences (EW) given the strong demand for its RESILIA tissue valves and the PASCAL system.

Zacks Equity Research

Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

by Zacks Equity Research

Investors are optimistic about Quest Diagnostics (DGX) owing to a strong recovery in base business and raised 2022 outlook.

Zacks Equity Research

AMN Healthcare (AMN) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

AMN Healthcare's (AMN) first-quarter results are likely to reflect solid demand in some of the areas of its business.

Zacks Equity Research

AMN Healthcare Services (AMN) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $103.49, marking a -1.14% move from the previous day.

Zacks Equity Research

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Retain Integra (IART) Stock For Now

by Zacks Equity Research

Investors are optimistic about Integra (IART), given the strength in its CSS arm and notable product launches.

Zacks Equity Research

Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results

by Zacks Equity Research

Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.

Zacks Equity Research

AMN Healthcare Services (AMN) Stock Moves -0.87%: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $108.82, marking a -0.87% move from the previous day.

Zacks Equity Research

Here is Why Growth Investors Should Buy AMN Healthcare (AMN) Now

by Zacks Equity Research

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Here's Why You Should Retain Baxter (BAX) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio and regulatory clearances.

Zacks Equity Research

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.

Zacks Equity Research

Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio

by Zacks Equity Research

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Zacks Equity Research

Here's Why You Should Hold on to Illumina (ILMN) Stock For Now

by Zacks Equity Research

Investors are optimistic about Illumina's (ILMN) strategic collaborations and strong international sales.

Zacks Equity Research

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

by Zacks Equity Research

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

Zacks Equity Research

Merit Medical's (MMSI) Latest Launch to Boost Patient Outcome

by Zacks Equity Research

Merit Medical's (MMSI) latest well-designed tray is expected to simplify the thoracostomy procedure and reduce treatment time, especially in critical situations.

Zacks Equity Research

Here's Why You Should Retain Bio-Rad (BIO) Stock For Now

by Zacks Equity Research

Investors are optimistic about Bio-Rad (BIO) owing to a recovery in most of its key global markets as well as an uptick in demand for COVID-related products.

Zacks Equity Research

Patterson Companies (PDCO) Moves Up 12.5%: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Patterson Companies' (PDCO) robust segmental performance and strong prospects in the dental space.